Amitriptyline in Migraine Prophylaxis

Archives of Neurology

Volumn 36, Issue 11, 1979, Pages 695-699

  Couch, James R ^a,b   Hassanein, Ruth S ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; PLACEBO;

ADVERSE DRUG REACTION; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE TIME EFFECT RELATION; DRUG SCREENING; DRUG TOLERANCE; HUMAN; MIGRAINE; ORAL DRUG ADMINISTRATION; PREVENTION; RANDOMIZED CONTROLLED TRIAL;

AMITRIPTYLINE; CASE REPORT; DEPRESSION; DOUBLE-BLIND METHOD; HUMAN; MIGRAINE;

EID: 0018726947     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.1979.00500470065013     Document Type: Article

References (37)

1. Friedman AP: The migraine syndrome. Bull NY Acad Med 44:45–62, 1968.
2. Mahloudji M: Prevention of migraine. Br Med J 1:182–183, 1969.
3. Gomersall JD, Stuart A: Amitriptyline in migraine prophylaxis. J Neurol Neurosurg Psychiatry 36:684–690, 1973.
4. Andersson PG: Treatment of migraine patients with amitriptyline. Nord Psykiat 28:227–230, 1974.
5. Couch JR, Ziegler DK, Hassanein RS: Amitriptyline in the prophylaxis of migraine. Neurol 26:121–127, 1976.
6. Couch JR, Ziegler DK, Hassanein RS: Evaluation of the relationship between migraine headaches and depression. Headache 15:41–50, 1975.
7. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62, 1960.
8. Zung WWK: A self-rating depression scale. Arch Gen Psychiatry 12:63–70, 1965.
9. Zung WWK: The diagnosis and treatment of depression. Arch Gen Psychiatry 29:328–337, 1973.
10. Ziegler VE, Co BT, Taylor JR, et al: Amitriptyline plasma levels and therapeutic response. Clin Pharmacol Ther 19:795–801, 1976.
11. Lance JW, Fine RD, Curran DA: An evaluation of methysergide in the prevention of migraine and other vascular headaches. Med J Aust 1:814–818, 1963.
12. Curran DA, Lance JW: Clinical trial of methysergide and other preparations in the management of migraine. J Neurol Neurosurg Psychiatry 27:463–469, 1964.
13. Friedman AP: Studies in the pharmacotherapy of headache. Neurol 13(suppl):27–33, 1963.
14. Pedersen E, Moller CE: Methysergide in migraine prophylaxis. Clin Pharmacol Ther 7:520–526, 1966.
15. Graham JR: Methysergide for prevention of headache: Experience in 500 patients over three years. N Engl J Med 270:67–72, 1964.
16. Barrie MA, Fox WR, Weatherall M, et al: Analysis of symptoms of patients with headaches and their response to treatment with ergot derivatives. Q J Med 146:319–336, 1968.
17. Lance JW, Anthony M, Somerville B: Comparative trial of serotonin antagonists in the management of migraine. Br Med J 2:327–330, 1970.
18. Herrmann WM, Horowski R, Dannehl K, et al: Clinical effectiveness of lisuride hydrogen maleate: A double-blind trial versus methysergide. Headache 17:54–60, 1977.
19. Weber RB, Reinmuth OM: The treatment of migraine with propranolol. Neurol 22:366–369, 1972.
20. Borgesen SE, Lanng-Nielsen J, Moller CE: Prophylactic treatment of migraine with propranolol. Acta Neurol Scand 50:651–656, 1974.
21. Ludvigsson J: Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand 50:109–115, 1974.
22. Forssman B, Henriksson K-G, Johannsson V, et al: Propranolol for migraine prophylaxis. Headache 16:238–245, 1976.
23. Stensrud P, Sjaastad O: Short-term clinical trial of propranolol in racemic form (Inderal), D-Propranolol and placebo in migraine. Acta Neurol Scand 53:229–232, 1976.
24. Lance JW, Anthony M: Clinical trial of a new serotonin antagonist, BC105, in the prevention of migraine. Med J Aust 1:54–55, 1968.
25. Sjaastad O, Stensrud P: Appraisal of BC-105 in migraine prophylaxis. Acta Neurol Scand 45:594–600, 1969.
26. Arthur GP, Hornabrook RW: Treatment of migraine with BC105: A double blind trial. N Zealand Med J 73:5–9, 1971.
27. Sicuteri F, Del Bianco PL, Anselmi B: Migraine as a cyclic disease with latent and overt components: Effects with an antaminic drug. Headache 10:53–62, 1970.
28. Krakowski AJ, Engisch R: A new agent for chemotherapy of migraine headaches: A controlled study. Psychosomatics 14:302–308, 1973.
29. Lawrence ER, Hossain M, Littlestone W: Sanomigran for migraine prophylaxis: Controlled multicenter trial in general practice. Headache 17:109–112, 1977.
30. Sjaastad O, Stensrud P: 2-(2.6-dichlorophenylamino)-2-imidazoline hydrochloride ST 155 (or Catapresan) as a prophylactic remedy against migraine. Acta Neurol Scand 47:120–122, 1971.
31. Sjaastad O, Stensrud P: Dixarit in migraine prophylaxis: A clinical study, in The Migraine Headache and Dixarit. Proceedings of a Symposium (Boehringer Ingelheim, 1972).
32. Anthony M, Lance JW, Somerville B: A comparative trial of pindolol, clonidine and carbamazepine in the interval therapy of migraine. Med J Aust 1:1343–1346, 1972.
33. Heathfield KWG, Raiman JD: The longterm management of migraine with clonidine. Practitioner 208:644–648, 1972.
34. White G: Clinical evaluation of clonidine in the treatment of migraine. Med J Aust 1:663, 1975.
35. Stensrud P, Sjaastad O: Clonidine (Catapresan): Double-blind study after long-term treatment with the drug in migraine. Acta Neurol Scand 53:233–236, 1976.
36. Horn AS: The interaction of tricyclic antidepressants with the biogenic amine uptake systems in the central nervous system. Postgrad Med J 52(suppl):25–30, 1976.
37. Cairncross KD: On the peripheral pharmacology of amitriptyline. Arch Intern Pharmacodyn Ther 154:438–448, 1964.